The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals

Author List
Stephanie Popping
Debora Bade
Charles Boucher
Mark van der Valk
Manal El-Sayed
Olafsson Sigurour
Vana Sypsa
Timothy Morgan
Amiran Gamkrelidze
Constance Mukabatsinda
Sylvie Deuffic-Burban
Michael Ninburg
Jordan Feld
Margaret Hellard
John Ward

Abstract

Hepatitis B virus (HBV) and hepatitis C virus (HCV) affect more than 320 million people worldwide, which is more than HIV, tuberculosis (TB) and malaria combined. Elimination of HBV and HCV will, therefore, produce substantial public health and economic benefits and, most importantly, the prevention of 1.2 million deaths per year. In 2016, member states of the World Health Assembly unanimously adopted a resolution declaring that viral hepatitis should be eliminated by 2030. Currently, few countries have elimination programmes in place and even though the tools to achieve elimination are available, the right resources, commitments and allocations are lacking. During the fifth International Viral Hepatitis Elimination Meeting (IVHEM), 7–8 December 2018, Amsterdam, the Netherlands, an expert panel of clinicians, virologists and public health specialists discussed the current status of viral hepatitis elimination programmes across multiple countries, challenges in achieving elimination and the core indicators for monitoring progress, approaches that have failed and successful elimination plans.

Article Category

Hepatitis

Article Type

Conference report

Posted Date

15-01-2019

Tables & Figures

Back to top